Twist Bioscience Corp (TWST) stock price

Twist Bioscience Corp (TWST) is a Healthcare · Diagnostics & Research company listed on NASDAQ. Price $160.85 (+3.40%), Market cap $3.08B, 52-week low–high $24.16 ~ $63.20.

Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo pools used in targeted NGS, CRISPR gene editing, mutagenesis experiments, DNA origami, DNA computing, data storage in DNA, and other applications; and immunoglobulin G proteins for customers focused on the pursuit of drug discovery and development. It also provides NGS tools comprising library prepar

Key metrics

Financial statements, price targets, institutional (13F) holdings and related news for Twist Bioscience Corp are updated in real time on BlackAll Trade.

Twist Bioscience Corp financial summary

Analyst outlook

Key ratios · profitability · growth

Frequently asked questions

What is the current Twist Bioscience Corp (TWST) stock price?

Twist Bioscience Corp trades at $160.85 (+3.40%). Real-time quotes and charts are available on BlackAll Trade.

What is the Twist Bioscience Corp (TWST) market cap?

Twist Bioscience Corp has a market cap of about $3.08B.

What does Twist Bioscience Corp (TWST) do?

Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemi